Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Trade-Ideas LLC identified

ZELTIQ Aesthetics

(

ZLTQ

) as a strong on high relative volume candidate. In addition to specific proprietary factors, Trade-Ideas identified ZELTIQ Aesthetics as such a stock due to the following factors:

  • ZLTQ has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $10.0 million.
  • ZLTQ has traded 228,990 shares today.
  • ZLTQ is trading at 4.51 times the normal volume for the stock at this time of day.
  • ZLTQ is trading at a new high 5.02% above yesterday's close.

'Strong on High Relative Volume' stocks are worth watching because major volume moves tend to indicate underlying activity such as M&A events, material stock news, analyst upgrades, insider buying, buying from 'superinvestors,' or that hedge funds and momentum traders are piling into a stock ahead of a catalyst. Regardless of the impetus behind the price and volume action, when a stock moves with strength and volume it can indicate the start of a new trend on which early investors can capitalize. In the event of a well-timed trading opportunity, combining technical indicators with fundamental trends and a disciplined trading methodology should help you take the first steps towards investment success.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in ZLTQ with the Ticky from Trade-Ideas. See the FREE profile for ZLTQ NOW at Trade-Ideas

More details on ZLTQ:

ZELTIQ Aesthetics, Inc., a medical technology company, is engaged in developing and commercializing non-invasive products for the selective reduction of fat. It offers CoolSculpting system, which utilizes proprietary controlled-cooling technology to selectively reduce stubborn fat bulges.

The average volume for ZELTIQ Aesthetics has been 498,300 shares per day over the past 30 days. ZELTIQ Aesthetics has a market cap of $574.5 million and is part of the health care sector and health services industry. The stock has a beta of 0.15 and a short float of 11% with 8.62 days to cover. Shares are down 11.2% year-to-date as of the close of trading on Tuesday.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null